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Case report
The patient was diagnosed with WS at the age of two years based on typical clinical characteristics including facial dysmorphia, a heart murmur due to supravalvular stenosis, growth deficiency and delay in neurological development. deletion at chromosome 7q11.23 ( Fig. 1) , compatible with the Williams syndrome diagnosis. The deletion consists of 27 genes including CLIP2, GTF2IRD1 and GTF2I, and can be categorized as "classical" according to Delgado et al [2] . No other constitutive genetic changes were identified and both parents had normal array-CGH results. (Table I) , only cases with Burkitt lymphoma have presented with chromosomal translocations. It is intriguing that our patient had two separate malignancies with a tumor-specific chromosomal translocation in both. As genetic data on tumors accumulates, it is interesting to see if chromosomal translocations are more common in tumors among WS patients.
Secondary malignancies after Burkitt lymphoma are rare. Only a few reports have been published on Ewing sarcoma as a secondary malignancy and, among these, Burkitt lymphoma was the primary cancer in only one case [20] . As a chemotherapy, our patient received doxorubicin and cyclophosphamide, and one possibility is that the primary treatment contributed to the occurrence of the Ewing sarcoma.
In summary, we report a unique patient with a constitutional chromosome alteration (WS) and two separate malignant tumors, both carrying aberrant fusion events. Array-CGH did not reveal any additional genetic lesions in our patient. However, our analysis does not rule out the possibility of minor insertions, deletions or mutations not identifiable at the level of array-CGH analysis. 
